1.
Heart failure
by Metra, Marco, MD
The Lancet (British edition), 2017, Vol.390 (10106), p.1981-1995

2.
Arterial Stiffness and risk of Overall Heart Failure, Heart Failure with Preserved Ejection Fraction, and Heart Failure with Reduced Ejection Fraction: The Health ABC Study
by Pandey, Ambarish Ambarish
Hypertension (Dallas, Tex. 1979), 2016, Vol.69 (2), p.267-274

3.
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
by Böhm, Michael, Prof
The Lancet (British edition), 2010, Vol.376 (9744), p.886-894

4.
Improving end-of-life care for patients with chronic heart failure: “Let’s hope it’ll get better, when I know in my heart of hearts it won’t”
by Selman, Lucy
Heart (British Cardiac Society), 2007, Vol.93 (8), p.963-967

5.
Patients with New York Heart Association class III heart failure may benefit with high flow nasal cannula supportive therapy: high flow nasal cannula in heart failure
by Roca, Oriol
Journal of critical care, 2013, Vol.28 (5), p.741-746

6.
Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure—A Pilot Study (PRONTO)
by Peacock, W. Frank
The American heart journal, 2014, Vol.167 (4), p.529-536

8.
Temporal Trends and Factors Associated With Diabetes Mellitus Among Patients Hospitalized With Heart Failure - Findings From Get With The Guidelines–Heart Failure Registry
by Echouffo-Tcheugui, Justin B., MD, PhD
The American heart journal, 2016, Vol.182, p.9-20

9.
Rheumatic heart disease
by Marijon, Eloi, Dr
The Lancet (British edition), 2012, Vol.379 (9819), p.953-964

10.
Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603 838 individuals
by Kivimäki, Mika, Prof
The Lancet (British edition), 2015, Vol.386 (10005), p.1739-1746

11.
Heart failure
by Krum, Henry, Prof
The Lancet (British edition), 2009, Vol.373 (9667), p.941-955

12.
Birth prevalence of congenital heart defects in Norway 1994-2009—A nationwide study
by Leirgul, Elisabeth, MD
The American heart journal, 2014, Vol.168 (6), p.956-964

13.
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
by Swedberg, Karl, Prof
The Lancet (British edition), 2010, Vol.376 (9744), p.875-885

14.
Mending a broken heart?: Commentary on Joseph et al, “Identifying the Broken Heart…”
by Kaiser, Larry R
The American journal of surgery, 2016, Vol.211 (6), p.989-990

15.
Heart Failure 4: Telemedicine and remote management of patients with heart failure
by Stefan D Anker
The Lancet (British edition), 2011, Vol.378 (9792), p.731

16.

17.
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)
by Herlitz, Johan
The Lancet (British edition), 1999, Vol.353 (9169), p.2001-2007

18.
Diuretic response in acute heart failure—an analysis from ASCEND-HF
by ter Maaten, Jozine M., MD
The American heart journal, 2015, Vol.170 (2), p.313-321.e4

19.
Predictors of mortality after discharge in patients hospitalized with heart failure: An analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patient...
by O'Connor, Christopher M., MD
The American heart journal, 2008, Vol.156 (4), p.662-673

20.
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
by Maggioni, Aldo P
The American heart journal, 2005, Vol.149 (3), p.548-557
